Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease.
about
Glucose regulates mitochondrial motility via Milton modification by O-GlcNAc transferase.O-GlcNAcylation regulates EZH2 protein stability and functionAutosomal recessive phosphoglucomutase 3 (PGM3) mutations link glycosylation defects to atopy, immune deficiency, autoimmunity, and neurocognitive impairmentGlycosylation of matrix metalloproteases and tissue inhibitors: present state, challenges and opportunitiesEnzymes for N-Glycan Branching and Their Genetic and Nongenetic Regulation in CancerGlycomic Approaches for the Discovery of Targets in Gastrointestinal CancerPost-Translational Modifications of Cardiac Mitochondrial Proteins in Cardiovascular Disease: Not Lost in TranslationDysregulated metabolism contributes to oncogenesisN-acetylglucosamine Regulates Virulence Properties in Microbial PathogensThe nuclear envelope LEM-domain protein emerinIdentification of aberrant pathways and network activities from high-throughput dataThree Decades of Research on O-GlcNAcylation - A Major Nutrient Sensor That Regulates Signaling, Transcription and Cellular MetabolismFOXO transcription factors throughout T cell biologyMass spectrometry-based detection and assignment of protein posttranslational modificationsPost-translational modifications of intermediate filament proteins: mechanisms and functionsProteolysis of HCF-1 by Ser/Thr glycosylation-incompetent O-GlcNAc transferase:UDP-GlcNAc complexes.Proteome wide purification and identification of O-GlcNAc-modified proteins using click chemistry and mass spectrometryO-GlcNAc transferase invokes nucleotide sugar pyrophosphate participation in catalysisA neutral diphosphate mimic crosslinks the active site of human O-GlcNAc transferaseRing cycle for dilating and constricting the nuclear poreStructure of a Novel O -Linked N -Acetyl-d-glucosamine ( O -GlcNAc) Transferase, GtfA, Reveals Insights into the Glycosylation of Pneumococcal Serine-rich Repeat AdhesinsO-GlcNAcylation and oxidation of proteins: is signalling in the cardiovascular system becoming sweeter?Heterogeneity of glycolysis in cancers and therapeutic opportunities.A Convenient Approach to Stereoisomeric Iminocyclitols: Generation of Potent Brain-Permeable OGA InhibitorsA critical perspective of the diverse roles of O-GlcNAc transferase in chromatinProteomics of protein post-translational modifications implicated in neurodegenerationEnzymatic methods for glyco(diversification/randomization) of drugs and small moleculesProtein quality control and metabolism: bidirectional control in the heartMutations in EOGT confirm the genetic heterogeneity of autosomal-recessive Adams-Oliver syndromeCircadian regulation of metabolismIntegrative biological analysis for neuropsychopharmacologyRedox biology and the interface between bioenergetics, autophagy and circadian control of metabolismTranscription factor Nrf1 is negatively regulated by its O-GlcNAcylation statusO-GlcNAc signaling entrains the circadian clock by inhibiting BMAL1/CLOCK ubiquitinationDiscovery and confirmation of O-GlcNAcylated proteins in rat liver mitochondria by combination of mass spectrometry and immunological methodsIncreasing brain protein O-GlcNAc-ylation mitigates breathing defects and mortality of Tau.P301L miceDistinct OGT-Binding Sites Promote HCF-1 CleavageIdentification of New Candidate Genes and Chemicals Related to Esophageal Cancer Using a Hybrid Interaction Network of Chemicals and ProteinsChronic Uridine Administration Induces Fatty Liver and Pre-Diabetic Conditions in MiceMicrofibril-associated glycoprotein 2 (MAGP2) loss of function has pleiotropic effects in vivo
P2860
Q24300267-0003FEA7-AF56-4BEB-B8A1-BBBB82A591A3Q24324113-271C1F97-25E3-4D86-929D-817C9809D896Q24338530-B6F44969-052C-478F-AE86-4351F93F13C2Q26745510-A4FF65CF-0782-4BB0-8550-42FD5BE127AFQ26748089-9D569744-35A9-47EF-B74B-ED6AFA4C2F96Q26750872-BCD8D370-E9AF-40F6-AABA-3009F98A52FEQ26769979-40DCD769-26D6-47D9-BA0D-D2EDD667D65AQ26784630-8BC32765-AEC7-4D32-9B9C-165E40D0B0D4Q26801453-7DC081A1-1E45-4712-AF58-4368969C9F6AQ26826857-CE6BA636-7E3A-4307-A2C1-FF5E93F8CEAEQ26829854-42F6194A-2301-47BF-BC5E-E3634AEAB348Q26853027-43051048-E6BF-4AB3-AB00-DB7DAF230A31Q26853741-7AA0FABE-EEB4-4921-B1D8-5B33BC4F7EEBQ27001576-022DC643-B1AA-4E3D-B335-E8616144CD68Q27004670-C5BDDDDB-7572-4349-904C-510723F3B1F4Q27322397-06AD715F-1B07-4005-B37A-C172D7B858CFQ27334695-F7CCE4E5-993B-4EF9-B676-D48F1FE8CD0BQ27674743-CFE0D7AE-063C-4944-A032-476054BBE281Q27675565-CBE73599-21FA-448E-83C4-320EDA155B82Q27676759-6824E1F6-341A-4960-A978-59AF3A44F858Q27684362-524AC318-0457-4B8B-9404-6038B366E72EQ27693206-2CDC33EC-5EBE-470E-B034-CC5368AB6E3DQ27693375-C93BC9AE-F860-460F-8E12-105FB573CCB6Q27702580-0A51C103-682C-4BB8-A7DD-D795E8AE6FDCQ28080440-510B4FA7-A69F-4CAA-ACFA-58444A29BCC4Q28088631-54396E34-4B13-480F-B0B3-FE4FED85C758Q28247479-A03D6B40-D290-4B75-94A7-E5A2BC8426F1Q28256472-DDCB9282-90F8-4937-9CA8-53DAE409AF93Q28287700-9159F0D8-70A3-43B5-B4B2-AA819A283B04Q28390852-0177513C-C3C8-4925-BCB3-3CA4F3331393Q28392635-09EE00C2-B70E-4BF4-9528-0C1C3D3AC382Q28394996-9C5A61F5-501C-4C93-BBBB-236E36CF0C84Q28507099-8299A6D1-53CD-4A57-AD7C-D71817B534AEQ28513755-151D5924-86D1-4F62-BA94-807E101CA3B1Q28533987-EA63C340-12A9-499D-94DC-C3A59EDB271FQ28537913-477A496B-4ADE-45E0-B890-CFE9CCF21D90Q28547471-0C2B3E91-8F5E-4FED-8121-99C7D43BE6BDQ28548040-5DF713AB-38DE-4939-88AB-8F46F01A2FC8Q28552696-0782F5B4-7854-43C4-97F8-FB9819BBB8CBQ28584810-F6A7BD96-84C6-4D40-8640-82817B8F293D
P2860
Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Cross talk between O-GlcNAcyla ...... cription, and chronic disease.
@ast
Cross talk between O-GlcNAcyla ...... cription, and chronic disease.
@en
type
label
Cross talk between O-GlcNAcyla ...... cription, and chronic disease.
@ast
Cross talk between O-GlcNAcyla ...... cription, and chronic disease.
@en
prefLabel
Cross talk between O-GlcNAcyla ...... cription, and chronic disease.
@ast
Cross talk between O-GlcNAcyla ...... cription, and chronic disease.
@en
P2093
P2860
P1476
Cross talk between O-GlcNAcyla ...... cription, and chronic disease.
@en
P2093
Chad Slawson
Genaro Ramirez-Correa
Gerald W Hart
Olof Lagerlof
P2860
P304
P356
10.1146/ANNUREV-BIOCHEM-060608-102511
P577
2011-01-01T00:00:00Z